STOCKHOLM, February 28, 2017 – Karo Pharma AB today announces that the company´s total number of shares as per February 28, 2017 amount to 82,166,391 shares, corresponding to an equal number of votes. The increase in the number of shares and votes results from the recently completed share issue of 18,259,198 shares. The issue was announced on December 15, 2016.
For further information, please contact:
Henrik Palm, CFO, telephone +46 70 540 40 14 or e-mail firstname.lastname@example.org
About Karo Pharma
Karo Pharma is a specialty pharma company that develops and markets products to pharmacies and to healthcare providers. The share is listed on Nasdaq Stockholm in the Mid Cap segment.
The information in this report is such that Karo Pharma is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on February 28, 2016 at 3.00 p.m. CET.